KERNAL BIO Trademark
Trademark Overview
On Monday, July 18, 2022, a trademark application was filed for KERNAL BIO with the United States Patent and Trademark Office. The USPTO has given the KERNAL BIO trademark a serial number of 97507488. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, April 21, 2025. This trademark is owned by Kernal Biologics. The KERNAL BIO trademark is filed in the Pharmaceutical Products and Chemical Products categories with the following description:
Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes
Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scienti...
General Information
| Serial Number | 97507488 |
| Word Mark | KERNAL BIO |
| Filing Date | Monday, July 18, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, April 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 3, 2024 |
Trademark Statements
| Goods and Services | Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes |
| Goods and Services | Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; nucleic acid sequences for scientific purposes; polypeptide encoding nucleic acids for laboratory use |
| NOT AVAILABLE | "BIO" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 8, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 8, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Kernal Biologics |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Kernal Biologics |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 3, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, July 21, 2022 | NEW APPLICATION ENTERED |
| Monday, August 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 3, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, May 3, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 21, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, July 21, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, October 18, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, October 18, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 18, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 18, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 18, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 30, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 4, 2023 | FINAL REFUSAL E-MAILED |
| Monday, December 4, 2023 | FINAL REFUSAL WRITTEN |
| Monday, December 4, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, August 1, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 1, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 1, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, August 1, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, April 21, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 21, 2025 | SOU EXTENSION 1 FILED |
| Monday, April 21, 2025 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 22, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
